Interventional Techniques for Managment of Chronic Low Back Pain
Comparative Study Between CT Guided and Fluoroscopic Guided Interventional Techniques for Management of Chronic Low Back Pain
1 other identifier
interventional
100
1 country
1
Brief Summary
Identify the efficacy of difference procedures of imaging guidance for needles for interventional treatments of low back pain (LBP) associated with sciatica and to study results and satisfaction of the patients between different groups.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable low-back-pain
Started Dec 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 14, 2022
CompletedFirst Posted
Study publicly available on registry
November 14, 2022
CompletedStudy Start
First participant enrolled
December 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2023
CompletedNovember 14, 2022
November 1, 2022
10 months
October 14, 2022
November 5, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Control of pain by transforaminal epidural steroid injection combined with pulsed radio frequency guided by CT or fluoroscopy
Interventional radiologists already possess the technical skills necessary to perform these interventions effectively. Pulsed radiofrequency is one of the interventional therapies for LBP, which uses radiofrequency alternating current to ablate the tissue around the needle electrode. Transforaminal epidural steroid injection (TFESI), as a minimally invasive interventional surgery, is widely used in the treatment of LBP. It has the advantages of less trauma, fewer complications, and faster onset. It relieves symptoms by injecting corticosteroids and local anesthetics around the dural and nerve roots that cause radicular pain. TFESI combined with PRF for the treatment of RLBP effectively and rapidly relieve radicular pain, reduce VAS (visual analog scale), relieve pain symptoms, improve the quality of life, cure rate, and satisfaction of patients, as well as, achieve long-term remission.
Up to 4 weeks
Study Arms (2)
CT guided for patient with chronic low back pain
ACTIVE COMPARATORCT guided treatment in patients with low back pain
Flouroscopic guided for patient wit chronic low back pain
ACTIVE COMPARATORFlouroscopic guided treatment in patients with low back pain
Interventions
Patients will be grouped into two groups, the first group (Group A) included patients who were subjected to fluoroscopic guided injection, and the second group (Group B) will include patients who were subjected to CT guided injections.
Eligibility Criteria
You may qualify if:
- Patients with chronic radicular low back pain with unilateral or bilateral sciatica that persisted for more than 6 months and failed medical treatment for 6 weeks.
- Pain exacerbates by leaning forward and flexion of the body with numbness and tingling in the legs.
- Visual analog scale (VAS) of pain severity ≥ 5 related specifically to the daily LBP.
- Patient develops calf and leg pain of leg raising test.
- No neurological motor deficits
You may not qualify if:
- Evidance of progressive motor neurological deficits.
- Magnetic resonance imaging show evidence of \> 3 degenerated discs.
- Intervertebral disc herniation ≥ 4 mm, disc sequestration, extrusion, disc space collapse or spondylolisthesis at the symptomatic level.
- Moderate to severe central spinal canal or foraminal stenosis
- Prior lumbar surgery of any kind at the same treatment level
- Spinal fractures, deformities, infection or tumors.
- History of uncontrolled coagulopathy or uncontrollable bleeding
- Patients with psychotic illness, advanced hepatic, uncontrolled diabetic patients.
- Current pregnancy, recent delivery (within 3-months of consent), or the intent of becoming pregnant during the study period.
- Local sepsis or skin inflammatory in the back region.
- Patients with red flags.
- Neurologic findings (Fecal or urinary incontinence and cauda equina syndrome).
- Persistent fever (infection).
- Prolonged use of corticosteroids.
- Pregnancy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Faculty of medicine
Asyut, 71511, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Faculty Of Medicine
Assiut University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Doctor
Study Record Dates
First Submitted
October 14, 2022
First Posted
November 14, 2022
Study Start
December 1, 2022
Primary Completion
October 1, 2023
Study Completion
December 1, 2023
Last Updated
November 14, 2022
Record last verified: 2022-11